Insider Selling: Colgate-Palmolive (NYSE:CL) COO Sells $3,311,350.00 in Stock

Colgate-Palmolive Company (NYSE:CLGet Free Report) COO Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total value of $3,311,350.00. Following the completion of the transaction, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at approximately $985,363.15. This represents a 77.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Panagiotis Tsourapas also recently made the following trade(s):

  • On Thursday, February 12th, Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00.

Colgate-Palmolive Stock Up 0.5%

Colgate-Palmolive stock traded up $0.44 during trading hours on Friday, hitting $96.61. The stock had a trading volume of 5,148,337 shares, compared to its average volume of 7,565,393. The stock’s 50-day moving average price is $83.43 and its 200-day moving average price is $81.83. The stock has a market capitalization of $77.87 billion, a P/E ratio of 36.87, a price-to-earnings-growth ratio of 4.30 and a beta of 0.29. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.91 EPS. Equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

Analysts Set New Price Targets

Several analysts have commented on CL shares. Bank of America increased their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Argus restated a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Raymond James Financial reduced their price target on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Jefferies Financial Group raised their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Finally, Citigroup lifted their target price on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $94.38.

Read Our Latest Stock Report on CL

Institutional Trading of Colgate-Palmolive

Institutional investors and hedge funds have recently modified their holdings of the stock. HighPoint Advisor Group LLC boosted its stake in shares of Colgate-Palmolive by 0.7% in the fourth quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock worth $1,255,000 after acquiring an additional 109 shares during the last quarter. Clear Harbor Asset Management LLC boosted its stake in Colgate-Palmolive by 2.6% during the 4th quarter. Clear Harbor Asset Management LLC now owns 4,503 shares of the company’s stock worth $356,000 after purchasing an additional 113 shares during the last quarter. Moneta Group Investment Advisors LLC boosted its stake in Colgate-Palmolive by 0.7% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,506 shares of the company’s stock worth $1,225,000 after purchasing an additional 114 shares during the last quarter. Sunpointe LLC grew its holdings in shares of Colgate-Palmolive by 4.0% during the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after buying an additional 117 shares in the last quarter. Finally, RFG Advisory LLC lifted its stake in shares of Colgate-Palmolive by 1.4% in the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock worth $839,000 after buying an additional 123 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Read More

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.